The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

RCUS FINANCIAL STATEMENTS

Arcus Biosciences Inc — balance sheet, income statement and cash flow trends

RCUSArcus Biosciences Inc

🇺🇸 USA · NYSE · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-250 M0250 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue117 M $Gross Profit110 M $ · 94%Operating Income-486 M $ · -415%Pre-tax Income-452 M $ · -386%Net Income to Owners-452 M $ · -386%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue117 M $-17.0%
Gross Profit110 M $-22.0%
Operating Income-486 M $—
EBITDA-419 M $—
Net Income to Owners-452 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets924 M
  • Equity464 M $50%
  • Current Liabilities198 M $21%
  • Long-term Liabilities262 M $28%

Key Figures

YoY change
Total Assets924 M $-20.1%
Total Liabilities460 M $-26.4%
Total Equity464 M $-12.6%
Cash & ST Investments702 M $-29.6%
Total Debt101 M $+68.3%
Net Debt-49 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-500 M0500 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0-474 M $Operating63 M $Investing313 M $Financing-98 M $Net Change

Key Figures

YoY change
Operating Cash Flow-474 M $—
Capital Expenditures1 M $-66.7%
Free Cash Flow-475 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RCUS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.